Matt Bonam appointed as Executive Director at the BHF Data Science Centre
Matt Bonam has been appointed Executive Director of the BHF Data Science…
Phase III Trials Show Tozorakimab Reduces COPD Exacerbations with Promising Safety Profile
Phase III trials indicate that tozorakimab effectively reduces COPD exacerbations and shows…
Abu Dhabi Biobank and AstraZeneca Partner to Advance Precision Medicine and Translational Research
Abu Dhabi Biobank has partnered with AstraZeneca to leverage genomic research and…
Lebanon’s Health Ministry and AstraZeneca Partner on National Lung Cancer Prevention and Early Diagnosis Initiative
The Lebanese Ministry of Public Health and AstraZeneca have signed a Memorandum…
Abu Dhabi Launches First Festival of Health to Inspire Healthier Living Across the Community
A multi-week celebration designed to make healthy living fun, accessible, and part…
MoHAP, in collaboration with health authorities and AstraZeneca, launches national guideline for lung cancer screening and diagnosis
The Ministry of Health and Prevention (MoHAP), in collaboration with health authorities…
Imfinzi approved in the EU as first and only perioperative immunotherapy for muscle-invasive bladder cancer
Approval based on NIAGARA Phase III trial results which showed a 32%…
Datroway: A Novel TROP2‑Directed Therapy Approved for Lung Cancer
AstraZeneca and Daiichi Sankyo’s new antibody drug conjugate, Datroway (datopotamab deruxtecan), has received accelerated…
M42, AstraZeneca, and SOPHiA GENETICS launch UAE broad liquid biopsy initiative to transform cancer diagnosis and care
M42, a global health leader powered by technology, continues to pioneer artificial…
Sheikh Shakhbout’s Bold New Partnerships
Sheikh Shakhbout Medical City (SSMC) has taken a major step forward in…
